Home/Pipeline/HydroPICC

HydroPICC

Vascular Access (PICC)

CommercialActive

Key Facts

Indication
Vascular Access (PICC)
Phase
Commercial
Status
Active
Company

About Access Vascular

Access Vascular is addressing a significant unmet need in vascular access by commercializing catheters made from a proprietary hydrophilic biomaterial, branded as MIMIX® technology. Its flagship products, HydroPICC® and HydroMID®, are designed to dramatically reduce thrombus accumulation compared to standard polyurethane catheters, aiming to lower complication rates, improve patient experience, and reduce hospital costs. The company is in the commercial stage, actively selling its FDA-cleared devices into the hospital market, supported by pre-clinical and initial clinical data.

View full company profile

Therapeutic Areas